Tomáš Rohan

Dr. Tomáš Rohan

Department of Radiology and Nuclear Medicine, Brno University Hospital, Czechia
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2021 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
JVJan Valošek
Jan Valošek
RLRené Labounek
René Labounek
THTomáš Horák
Tomáš Horák
MHMagda Horáková
Magda Horáková
PBPetr Bednarik
Petr Bednarik
ASAlena Svátková
Alena Svátková
Background and purpose: Non‐myelopathic degenerative cervical spinal cord compression (NMDC) frequently occurs throughout aging and may progress to potentially irreversible degenerative cervical myelopathy (DCM). Whereas standard clinical magnetic resonance imaging (MRI) and electrophysiological measures assess compression severity and neurological dysfunction, respectively, underlying microstructural deficits still have to be established in NMDC and DCM patients. The study aims to establish tract‐specific diffusion MRI markers of electrophysiological deficits to predict the progression of asymptomatic NMDC to symptomatic DCM.Methods: High‐resolution 3 T diffusion MRI was acquired for 103 NMDC and 21 DCM patients compared to 60 healthy controls to reveal diffusion alterations and relationships between tract‐specific diffusion metrics and corresponding electrophysiological measures and compression severity. Relationship between the degree of DCM disability, assessed by the modified Japanese Orthopaedic Association scale, and tract‐specific microstructural changes in DCM patients was also explored.Results: The study identified diffusion‐derived abnormalities in the gray matter, dorsal and lateral tracts congruent with trans‐synaptic degeneration and demyelination in chronic degenerative spinal cord compression with more profound alterations in DCM than NMDC. Diffusion metrics were affected in the C3‐6 area as well as above the compression level at C3 with more profound rostral deficits in DCM than NMDC. Alterations in lateral motor and dorsal sensory tracts correlated with motor and sensory evoked potentials, respectively, whereas electromyography outcomes corresponded with gray matter microstructure. DCM disability corresponded with microstructure alteration in lateral columns.Conclusions: Outcomes imply the necessity of high‐resolution tract‐specific diffusion MRI for monitoring degenerative spinal pathology in longitudinal studies.

10 May 2019 in Digestive Diseases
Verified
Journal Article
Closed access
PDF file
PDPetr Dite
Petr Dite
INIvo Novotny
Ivo Novotny
JDJana Dvorackova
Jana Dvorackova
BKBohuslav Kianicka
Bohuslav Kianicka
MBMartin Blaho
Martin Blaho
LKLumir Kunovsky
Lumir Kunovsky
Background: Diagnosis of pancreatic cancer (PC) in early stages is still challenging for gastroenterologists. The early detection of cancer is one of the utmost importance for the successful therapy of this malignancy. An accurate differential diagnosis of focal pancreatic lesions plays also an important role, whether it is differential diagnosis of chronic pancreatitis from PC or autoimmune pancreatitis (AIP) from PC. Raised serum immunoglobulin G4 (IgG4) levels to twice the normal value are considered one of significant diagnostic features of type 1 AIP. However, IgG4 can be increased also in patients with PC, but levels usually do not exceed twice the normal value. Methods: In years 2012–2017, IgG4 serum levels were examined in 115 patients with histologically confirmed PC. Patients with PC and elevated IgG4 level (above 135 mg/dL) had tested their histological resection specimens or bioptic specimens from pancreatic lesion, with targeted detection of the presence of IgG4 and plasmocytes in the pancreatic tissue and changes characteristic for type 1 AIP. Results: A plasmatic IgG4 level in 115 patients with diagnosed PC was higher than 135 mg/dL in 14 patients (12.2%). Out of them, 2 patients (1.7%) revealed a serum IgG4 level higher than double the normal value, that is, higher than 270.0 mg/dL (suggestive of AIP). One patient met histological criteria for diagnosis of AIP in the simultaneous presence of PC. Conclusion: Diagnosis of early cancer stages, particularly differentiating AIP from PC can be sometimes problematic. IgG4 levels can be slightly elevated also in case of PC. A targeted biopsy of the pancreas is the method of choice in cases suspected from a focal form of AIP and we recommend to prefer it over other modalities, such as, for example, response to steroid therapy.

1 January 2022 in Contrast Media & Molecular Imaging
Verified
Journal Article
Open access
PDF file
HPHana Petrasova
Hana Petrasova
RSRadka Slaisova
Radka Slaisova
TRTomáš Rohan
Tomáš Rohan
KSKarel Stary
Karel Stary
JKJitka Kyclova
Jitka Kyclova
VVVlastimil Valek
Vlastimil Valek
Objectives. To extend and revise the diagnostic value of contrast‐enhanced ultrasonography (CEUS) for differentiation between malignant and benign thyroid nodules. Methods. This single‐institution prospective study aims to compare CEUS qualitative and objective quantitative parameters in benign and malignant thyroid nodules. Consecutive cohort of 100 patients was examined by CEUS, 68 out of them were further analysed in detail. All included patients underwent cytological and/or histopathological verification of the diagnosis. Results. Fifty‐five (81%) thyroid nodules were benign, and 13 (19%) were malignant. Ring enhancement pattern was strongly associated with a benign aetiology (positive predictive value 100%) and heterogeneous enhancement pattern with malignant aetiology (positive predictive value 72.7%). The shape of the TIC (time‐intensity curve) was more often identical in the benign lesion (98.2%) than in malignant lesions (69.2%), p = 0.004. Conclusions. This study indicates that CEUS enhancement patterns were significantly different in benign and malignant lesions. Ring enhancement was a very strong indicator of benign lesions, whereas heterogeneous enhancement was valuable to detect malignant lesions.

26 April 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
RPRobert Psar
Robert Psar
OUOndrej Urban
Ondrej Urban
MCMarie Cerna
Marie Cerna
TRTomáš Rohan
Tomáš Rohan
Martin HillMartin Hill
Martin Hill
(1) Background. The aim was to define typical features of isoattenuating pancreatic carcinomas on computed tomography (CT) and endosonography and determine the yield of fine-needle aspiration endosonography (EUS-FNA) in their diagnosis. (2) Methods. One hundred and seventy-three patients with pancreatic carcinomas underwent multiphase contrast-enhanced CT followed by EUS-FNA at the time of diagnosis. Secondary signs on CT, size and location on EUS, and the yield of EUS-FNA in isoattenuating and hypoattenuating pancreatic cancer, were evaluated. (3) Results. Isoattenuating pancreatic carcinomas occurred in 12.1% of patients. Secondary signs of isoattenuating pancreatic carcinomas on CT were present in 95.2% cases and included dilatation of the pancreatic duct and/or the common bile duct (85.7%), interruption of the pancreatic duct (76.2%), abnormal pancreatic contour (33.3%), and atrophy of the distal parenchyma (9.5%) Compared to hypoattenuating pancreatic carcinomas, isoattenuating carcinomas were more often localized in the pancreatic head (100% vs. 59.2%; p < 0.001). In ROC (receiver operating characteristic) analysis, the optimal cut-off value for the size of isoattenuating carcinomas on EUS was ≤ 25 mm (AUC = 0.898). The sensitivity of EUS-FNA in confirmation of isoattenuating and hypoattenuating pancreatic cancer were 90.5% and 92.8% (p = 0.886). (4) Conclusions. Isoattenuating pancreatic head carcinoma can be revealed by indirect signs on CT and confirmed with high sensitivity by EUS-FNA.

1 March 2021 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
TATomas Andrasina
Tomas Andrasina
JJJaroslav Juracek
Jaroslav Juracek
JZJan Zavadil
Jan Zavadil
BCBarbora Cechova
Barbora Cechova
TRTomáš Rohan
Tomáš Rohan
SGS. Nahum Goldberg
S. Nahum Goldberg

13 February 2019 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
TATomáš Andrašina
Tomáš Andrašina
JJJosef Jaroš
Josef Jaroš
TJTomáš Jůza
Tomáš Jůza
TRTomáš Rohan
Tomáš Rohan
DČDalibor Červinka
Dalibor Červinka
NGNahum S. Goldberg
Nahum S. Goldberg